Mechanism · Research Data · Side Effects · No Doses
Semax is a synthetic heptapeptide, an analogue of the adrenocorticotropic hormone (ACTH) fragment ACTH(4-10) with an additional Pro-Gly-Pro sequence. It belongs to a class of compounds investigated for their potential influence on cognitive functions and neuroprotection. Unlike ACTH, Semax lacks hormonal activity but retains the neuroregulatory properties associated with the parent molecule.
Research into Semax primarily explores its potential applications in areas related to neural plasticity, attention, memory, and resilience to stress. Its unique structure is thought to confer enhanced stability and targeted action within the central nervous system. This guide is for educational and research purposes only. Not medical advice.
| Evidence Type | Status |
|---|---|
| Human RCT | ✔ (primarily in specific regions, e.g., Russia) |
| Observational | ✔ (clinical use in specific regions) |
| Animal Studies | ✔ |
| In Vitro | ✔ |
| Regulatory Approval | ✗ (not approved for human therapeutic use by HPRA/HSA or major Western regulatory bodies) |
Semax is primarily understood to exert its effects through interactions within the brain's neuroregulatory systems. It is thought to modulate the activity of the melanocortin system, specifically interacting with melanocortin receptors (MC1, MC3, MC4, MC5), though its precise binding profile and downstream effects are areas of ongoing investigation. This interaction is hypothesised to influence various physiological processes, including neurogenesis, synaptic plasticity, and inflammatory responses within the central nervous system.
Experimental research has examined whether Semax affects neurotrophic factors such as Brain-Derived Neurotrophic Factor (BDNF) and Nerve Growth Factor (NGF), which are involved in neuronal survival, growth and differentiation. Models have also examined dopamine, serotonin and norepinephrine metabolism. These are proposed mechanisms from experimental work, not proof of a clinical effect.
Research has investigated Semax for its potential to support cognitive functions, particularly in areas of attention, memory, and learning. Animal models and some human studies (e.g., in Russia) have observed improvements in sustained attention, information processing speed, and the consolidation of memory. It has been investigated for its use in subjects experiencing cognitive fatigue or following conditions that impair cognitive performance.
Semax has been studied extensively for its neuroprotective properties, primarily in animal models of neurological injury. Research suggests it may offer protection against various forms of brain damage, including ischemic stroke, traumatic brain injury, and oxidative stress. Studies have observed a reduction in neuronal damage and improved functional recovery in these experimental models, potentially through mechanisms involving antioxidant activity and the modulation of inflammatory pathways.
Experimental models have investigated Semax's potential effects on mood and stress responses. Research in rodents has observed anxiolytic-like effects and a reduction in despair behaviours associated with depression-like states. These effects are thought to be mediated by its influence on monoamine neurotransmitter systems and the hypothalamic-pituitary-adrenal (HPA) axis, contributing to enhanced resilience against various stressors.
In vitro and animal studies have also examined whether Semax affects innate and adaptive immune responses and inflammation. This work concerns the link between the nervous and immune systems, often called neuroimmunomodulation. It remains experimental.
| Study / Model | Reported Effect |
|---|---|
| Rat model of transient cerebral ischemia | Significantly reduced neurological deficits and infarct volume. |
| Human study (healthy volunteers) | Observed improvements in selective attention and memory recall. |
| In vitro (primary neuronal cultures) | Increased expression of BDNF and NGF mRNA, suggesting neurotrophic support. |
| Animal model of chronic unpredictable stress | Reduced anxiety-like behaviour and normalized levels of stress hormones. |
| Human study (post-stroke recovery, specific region) | Faster recovery of cognitive functions and motor skills. |
| Mouse model of traumatic brain injury | Decreased neuronal apoptosis and attenuated inflammation. |
| Human study (glaucoma patients, specific region) | Reported improvements in visual field parameters and optic nerve function. |
No severe adverse events have been widely reported in available published literature concerning Semax research at standard experimental doses.
What is Semax?
Semax is a synthetic heptapeptide derived from a fragment of ACTH (adrenocorticotropic hormone) with an added Pro-Gly-Pro sequence. It has no hormonal activity itself but is researched for effects on attention, memory and stress resilience via the melanocortin system and neurotrophic factors such as BDNF.
Is Semax approved as a medicine in Ireland or the EU?
No. Semax has a body of human clinical and observational research, but that research and its clinical use has been concentrated in Russia. It is not approved for human therapeutic use by the HPRA, the EMA or Western regulatory bodies generally, and is treated as a research compound in Ireland.
What does the human research on Semax actually cover?
Published Russian-language clinical literature includes studies in mild cognitive impairment, post-stroke recovery and optic nerve atrophy, alongside animal research on neuroprotection in ischaemic and traumatic brain injury models. This is a genuinely larger human evidence base than most research peptides have, though it comes from a specific regional research and regulatory context rather than Western multi-centre RCTs.
How is Semax typically administered in research settings?
Semax has been researched almost exclusively via intranasal administration in the published literature, rather than injection. This site does not publish dosing information for any compound; anyone researching Semax should read the primary studies and speak with a doctor familiar with their own health history.
More evidence-based peptide research guides, free.
Browse the Research GuidesTracking food too? Calorie counter with barcode scanner →
